top of page
TODAY'S HEADLINES
FINANCE - LATEST
MINING - LATEST
SUBSCRIBE TO OUR NEWSLETTER
MINING
Nebraska Rare-Earth Discovery Grows as Apex Reports New Drilling
New drilling has extended Apex Critical Metals’ rare-earth discovery in Nebraska. The results strengthen the exploration case, while a planned 2027 resource estimate remains the next meaningful test for investors.
$400 Million US Backing Pulls Scandium Miner Toward Nasdaq
Sunrise Energy Metals plans to move its parent company to the US and pursue a Nasdaq listing alongside up to $400 million in government backing for its scandium project.
Norway’s Rare-Earth Deposit Could Strengthen Europe’s Mineral Supply
Norway is pushing ahead with the Fen Complex, a 15.9-million-tonne rare-earth resource that could strengthen Europe's critical-minerals supply chain.
America’s $7 Billion Minerals Plan Faces a Project-Level Test
The US is preparing up to $7 billion in financing for Argentine minerals and energy projects. Investors need to see which projects receive support and what it helps them build.
Copper Rally Puts Miners’ Production Under Scrutiny
Copper is approaching record highs as expectations of stronger Chinese demand support prices, placing greater attention on which miners can convert the rally into higher production and cash flow.
MOST POPULAR
FINANCE
Oil Retreats From $105 as Iran Tensions Ease
Oil prices have eased from $105 as US-Iran tensions show signs of cooling. Investors are watching the impact on energy stocks, inflation and interest-rate expectations.
KKR Expands US Solar Venture With $1.2 Billion Portfolio
KKR and TotalEnergies are adding a $1.2 billion solar portfolio to their US joint venture, with projects in Texas and Ohio expected to begin operating by early 2027.
Citi’s Turnaround Faces a Crucial Regulatory Test
Citi is pushing to resolve longstanding regulatory orders, a potential milestone that could free resources for growth and strengthen investor confidence in the bank’s wider turnaround strategy.
US–China Tariff Deal Gives Exporters a Narrower Opening
The US and China have agreed to tariff reductions covering $60 billion in trade. Exporters and retailers may benefit, but the value of the deal will depend on its final terms and implementation.
Oil prices climbed Thursday as markets saw little sign of a diplomatic breakthrough between the United States and Iran
Oil prices climbed Thursday as markets saw little sign of a diplomatic breakthrough between the United States and Iran.
INVESTING
Farm Equipment Stocks Slide as Competition Scrutiny Builds
Deere, AGCO and CNH shares fell as US regulators examined agricultural equipment market practices. Investors are watching for potential changes affecting machinery distribution, repair access and recurring service revenue.
Reported $3 Billion BD Expansion Puts Cash Flow in Focus
A reported $3 billion US manufacturing commitment puts Becton Dickinson’s spending plans in focus. Investors need company details on timing, cash-flow requirements and the expected returns from additional capacity.
Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)
Quantum BioPharma is preparing to put its multiple sclerosis drug to the test in patients. Getting there takes money. What happens next depends on the results. On October 6, the Toronto-based biotech announced an agreement with Thermo Fisher Scientific’s clinical research business to prepare a Phase 2 trial of Lucid-MS. The FDA has cleared the study to proceed. The experimental drug targets damage to myelin, the protective covering around nerves. Quantum reports encouraging p
Vistra’s Nuclear Expansion Could Receive $4.2 Billion US Loan
Vistra could receive about $4.2 billion in US financing to increase output at existing nuclear plants. An official announcement and the loan terms remain the key details for investors to watch.
Nuclear Stocks Have Cooled But the Bigger Investment Story May Still Be Heating Up
After one of the market's strongest rallies, nuclear energy stocks have cooled in 2026 as investors take a more cautious view of the sector. But while share prices have pulled back, the long-term drivers including AI's soaring electricity demand, energy security, and the global push for reliable clean power continue to support the investment case for nuclear energy.
PHARMACEUTICAL
UnitedHealth’s Earnings Beat Strengthens Its Turnaround
UnitedHealth beat earnings expectations and raised its annual profit forecast as medical costs improved. Sustaining stronger margins while stabilising insurance membership will be the next test for shareholders.
Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker
Shionogi is paying $2 billion for US drugmaker IntraBio and its approved rare-disease treatment Aqneursa. The investor question is whether future sales can justify the substantial price.
Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs
Novartis has struck an RNA licensing agreement with China’s Abogen worth up to $7.8 billion, highlighting Big Pharma’s continued race to secure promising new drug technologies.
Eli Lilly’s Next Obesity Drug Raises the Bar Again
Eli Lilly’s retatrutide delivered weight loss exceeding 25% for more than a third of high-dose patients, potentially strengthening the drugmaker’s position in the next generation of obesity treatments.
Novo Nordisk’s $23 Billion Growth Plan Fails to Reassure Investors
Novo Nordisk is targeting more than $23 billion in pipeline sales by 2035, but investors remain cautious as competition, pricing pressure and future patent expirations threaten the company’s long-term growth.
TECHNOLOGY
Microsoft’s AI PC Push Opens a New Front for Nvidia
Microsoft’s latest AI PC push creates a potential growth market for Nvidia. Adoption will depend on whether customers see enough productivity value to justify more expensive hardware.
$5 Billion AI IPO Collapse Raises Questions Over Tech Valuations
Firmus has shelved its planned $5 billion IPO amid market volatility and valuation concerns, highlighting growing investor scrutiny of expensive AI infrastructure projects.
Amazon’s Reported $7 Billion AI Bid Raises the Stakes
Amazon is reportedly considering a $7 billion acquisition of AI startup Decart, putting the potential commercial value of video AI and robotics simulation in focus for shareholders.
CCC Shares Jump as Takeover Talks Advance
CCC shares jumped after reports of advanced takeover talks with GTCR and Elliott, leaving investors focused on a potential offer price and the risk that negotiations fail.
AMD Targets Bigger AI Chip Supply in 2027
AMD plans a substantial chip supply increase in 2027 to meet AI demand. Investors will watch whether additional capacity translates into stronger sales, competitive gains and healthy margins.
bottom of page